1. Home
  2. HALO vs WCC Comparison

HALO vs WCC Comparison

Compare HALO & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • WCC
  • Stock Information
  • Founded
  • HALO 1998
  • WCC 1922
  • Country
  • HALO United States
  • WCC United States
  • Employees
  • HALO N/A
  • WCC N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • WCC Telecommunications Equipment
  • Sector
  • HALO Health Care
  • WCC Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • WCC Nasdaq
  • Market Cap
  • HALO 7.4B
  • WCC 8.1B
  • IPO Year
  • HALO N/A
  • WCC 1999
  • Fundamental
  • Price
  • HALO $56.07
  • WCC $167.86
  • Analyst Decision
  • HALO Buy
  • WCC Buy
  • Analyst Count
  • HALO 9
  • WCC 8
  • Target Price
  • HALO $63.56
  • WCC $212.00
  • AVG Volume (30 Days)
  • HALO 3.5M
  • WCC 635.2K
  • Earning Date
  • HALO 05-06-2025
  • WCC 05-01-2025
  • Dividend Yield
  • HALO N/A
  • WCC 1.08%
  • EPS Growth
  • HALO 55.40
  • WCC 10.34
  • EPS
  • HALO 3.76
  • WCC 13.26
  • Revenue
  • HALO $1,084,306,000.00
  • WCC $21,812,500,000.00
  • Revenue This Year
  • HALO $25.77
  • WCC $4.13
  • Revenue Next Year
  • HALO $18.01
  • WCC $4.27
  • P/E Ratio
  • HALO $14.92
  • WCC $12.66
  • Revenue Growth
  • HALO 25.64
  • WCC N/A
  • 52 Week Low
  • HALO $42.01
  • WCC $125.21
  • 52 Week High
  • HALO $70.51
  • WCC $216.17
  • Technical
  • Relative Strength Index (RSI)
  • HALO 48.34
  • WCC 52.67
  • Support Level
  • HALO $54.00
  • WCC $161.70
  • Resistance Level
  • HALO $55.25
  • WCC $175.36
  • Average True Range (ATR)
  • HALO 2.53
  • WCC 4.00
  • MACD
  • HALO 0.14
  • WCC -0.29
  • Stochastic Oscillator
  • HALO 42.01
  • WCC 41.51

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About WCC WESCO International Inc.

Wesco can be traced back to the late 1800s but was officially founded in 1922, acting as the distribution arm of Westinghouse Electric. Throughout the 1900s, Wesco entered and subsequently exited the consumer electronics, transit, bottling, and nuclear plant distribution markets. It was sold to a private equity firm in 1994 and then went public in 1999, and numerous acquisitions have since been made to fill the gaps in Wesco's geographical and product coverage. Today, the firm primarily distributes electrical, networking, security, and utility equipment used in the construction and repair of structures such as offices, data centers, power transmission lines, and manufacturing plants. Wesco has operations around the globe but generates the majority of its revenue in the United States.

Share on Social Networks: